Science Explorer Back to mapMap
Discussion
Researcher · Trinity Health · United States

Nikhil Vojjala

Nikhil Vojjala publishes mostly in Oncology, Hematology and Genetics, on topics such as CAR-T cell therapy research, Multiple Myeloma Research and Treatments and Biosimilars and Bioanalytical Methods.

ORCID 0000-0001-7238-1058 OpenAlex
World rank
#4,606,468
of 7,710,434 ranked researchers
Rank in United States
#1,219,044
of 1,627,098
Works
106
Citations
153
Citations per work
1.4
h-index
5
i10-index 4Top 89% in Oncology
Nikhil Vojjala

What does Nikhil Vojjala research?

Nikhil Vojjala's work is mostly in Medicine (48%), Economics, Econometrics and Finance (4%).

Health Sciences: 51 works · 48.4% of their workMedicine: 51 works · 48.4% of their workOncology: 17 works · 16.0% of their workHematology: 13 works · 11.9% of their workGenetics: 9 works · 8.6% of their workPulmonary and Respiratory Medicine: 8 works · 7.4% of their workEpidemiology: 5 works · 4.5% of their workEverything else: 51 works · 47.9% of their workSocial Sciences: 4 works · 3.7% of their workEconomics, Econometrics and Finance: 4 works · 3.7% of their workEconomics and Econometrics: 4 works · 3.7% of their workTHEIR WORKNikhil Vojjala106works
Health Sciences48%Social Sciences4%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine5148.4%
  2. Everything else5147.9%
    1. Economics, Econometrics and Finance43.7%
  1. 1Oncology16% of their works
  2. 2Hematology12% of their works
  3. 3Genetics9% of their works
  4. 4Pulmonary and Respiratory Medicine7% of their works
  5. 5Epidemiology4% of their works
  6. 6Economics and Econometrics4% of their works

Research topics

Which keywords describe Nikhil Vojjala's research?

The keywords of their largest research topics: CAR T Cells, Chimeric Antigen Receptor, Diagnosis Criteria, International Myeloma Working Group, Biosimilars, Immunogenicity, JAK2 Mutation and Myelofibrosis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. CAR T Cells201 topic
  2. Chimeric Antigen Receptor201 topic
  3. Diagnosis Criteria131 topic
  4. International Myeloma Working Group131 topic
  5. Biosimilars81 topic
  6. Immunogenicity81 topic
  7. JAK2 Mutation81 topic
  8. Myelofibrosis81 topic
  9. Sickle-cell Disease71 topic
  10. Thalassemia71 topic
  11. BCR-ABL61 topic
  12. Chronic Lymphocytic Leukemia61 topic
  13. EGFR Mutations61 topic
  14. Genomic Aberrations61 topic
  15. Imatinib61 topic
  16. Targeted Therapy61 topic

Where does Nikhil Vojjala work?

Nikhil Vojjala's main affiliation in the publication record is Trinity Health, United States.

How many publications and citations does Nikhil Vojjala have?

OpenAlex counts 106 works and 153 citations for Nikhil Vojjala, an h-index of 5, ranking #4,606,468 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Nikhil Vojjala. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.